Загрузка...
Optimizing drug outcomes through pharmacogenetics: A case for preemptive genotyping
Routine integration of genotype data into drug decision-making could improve patient safety, particularly if many relevant genetic variants can be assayed simultaneously before target drug prescribing. The frequency of pharmacogenetic prescribing opportunities and the potential adverse events (AE) m...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3785311/ https://ncbi.nlm.nih.gov/pubmed/22739144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2012.66 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|